Schedule 13G ownership disclosure

AKCEA THERAPEUTICS, INC.

Security class unavailable · CUSIP: 00972L107

Event date: 2017-07-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,250,000
Percent of class
9.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-17-047117
Form type
SC 13G
Filer
AKCEA THERAPEUTICS, INC.
CIK
CIK 1662524
Filed
Jul 27, 2017
Reporting period
Jul 19, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub